Results 141 to 150 of about 18,942 (235)

MC4R-related monogenic obesity in children: insights from 2 cases. [PDF]

Ann Pediatr Endocrinol Metab
Shanmugam D, Sridhar S, Kuppusamy N, Manjini K, Sreenivasan P, Kumar MA.   +5 more
europepmc   +1 more source

Diazoxide choline extended-release (DCCR) use in Prader-Willi syndrome: patient selection, dosing, and management. [PDF]

J Endocr Soc
Miller JM, Shoemaker AH, Salehi P, Mejia-Corletto J.   +3 more
europepmc   +1 more source

An Assessment of Obesity and Hyperphagia In Individuals With Smith-Magenis Syndrome

, 2010
Smith-Magenis syndrome (SMS;OMIM# 182290) is a multiple congenital anomalies and mental retardation syndrome caused by a 3.7- Mb deletion on chromosome 17p11.2 or a mutation in the RAI1 gene.
Crain, Carrie A
core  

Parathyroid hormone enhances appetite and fails to reduce adiposity in ob/ob mice. [PDF]

Pflugers Arch
Fajol A, Komaba H, Ishioka C, Nakagawa Y, Hamano N, Wada T, Fukagawa M.   +6 more
europepmc   +1 more source

Patient advocacy group perspectives on treatment priorities and clinical trials for the rare neurodevelopmental condition, Prader-Willi syndrome. [PDF]

Orphanet J Rare Dis
Holland A, Strong T, Schwartz L, Garrick L, Hoybye C, Tauber M, Hughes M.   +6 more
europepmc   +1 more source

Evidence of persistent hunger following dietary weight loss in mice. [PDF]

iScience
Heyward FD, Rosen ED.
europepmc   +1 more source

Genetic architecture of obesity and advances in precision pharmacotherapy: a comprehensive review. [PDF]

Acta Biochim Pol
Kavaja F, Liehr T, Temaj G.
europepmc   +1 more source

Severe respiratory complications in late-diagnosed Prader-Willi syndrome: a case report. [PDF]

J Med Case Rep
Tiwari SK, Joshi P, Mishra NR, Sonowal R, Bhunia NS.   +4 more
europepmc   +1 more source

Tirzepatide for weight and behavior management in a patient with Smith-Magenis syndrome. [PDF]

JCEM Case Rep
Liao XC, Huang T, Hong DS, Luo L.
europepmc   +1 more source

Diazoxide Choline Extended-release Tablets in Prader-Willi Syndrome: A Randomized, Double-blind, Withdrawal Period Study.

J Clin Endocrinol Metab
Miller JL, Bridges N, Felner EI, Salehi P, Yanovski JA, Stevenson DA, Mejia-Corletto J, Shaikh MG, Abuzzahab MJ, Fleischman A, Kimonis V, Shoemaker AH, Holland A, Bird LM, Obrynba KS, Lah M, Littlejohn E, Harwood K, Shea H, Viskochil D, Hirano P, Yen K, Ballal S, Huang M, Cowen NM, Bhatnagar A, Gevers E.   +26 more
europepmc   +1 more source